|
Generic Name : Axitinib Tablets
Trade Name(s):
International- Inlyta. This medication is a kinase inhibitor, prescribed for the treatment of advanced renal cell carcinoma after failure of one prior systemic therapy. When it is not to be taken (Contraindications):
When it is to be taken : PO- The initial recommended dose is 5mg/day. How it should be taken : It comes as a tablet to take by mouth, with or without food. Special Instruction : * Caution should be exercised in patients with history of high blood pressure, thyroid problem, liver impairment, blood clot events, bleeding problems, unhealed wound, who are taking other medications, any allergy, during pregnancy and breastfeeding. * Avoid drinking grapefruit juice or eat grapefruit while taking this medication. Side Effects : Most Common - Diarrhea, high blood pressure, fatigue, decreased appetite, nausea, loss of voice, hand-foot syndrome (palmar-plantar erythrodysesthesia), weight loss, vomiting, weakness and constipation. Miscellaneous - Hypothyroidism, cough, mucosal inflammation, joint pain, mouth ulcer, difficulty in breathing, abdominal pain, headache, pain in extremity, rash, protein in urine, taste disorder, indigestion, difficulty in swallowing, itching, hair loss, redness. * Avoid excess dosage. Storage Conditions : Store it at room temperature (20°C to 25°C). |
![]() Comment & Contribute
![]()
![]() ![]() | ||


